$133.22 Million in Sales Expected for Tivity Health, Inc. (NASDAQ:TVTY) This Quarter

Wall Street analysts predict that Tivity Health, Inc. (NASDAQ:TVTYGet Rating) will post sales of $133.22 million for the current fiscal quarter, according to Zacks Investment Research. Four analysts have issued estimates for Tivity Health’s earnings, with the highest sales estimate coming in at $137.01 million and the lowest estimate coming in at $127.40 million. Tivity Health posted sales of $108.09 million in the same quarter last year, which indicates a positive year over year growth rate of 23.2%. The firm is expected to report its next quarterly earnings report on Monday, January 1st.

According to Zacks, analysts expect that Tivity Health will report full-year sales of $557.78 million for the current financial year, with estimates ranging from $549.32 million to $565.73 million. For the next financial year, analysts expect that the company will report sales of $616.70 million, with estimates ranging from $596.01 million to $636.27 million. Zacks’ sales averages are a mean average based on a survey of research firms that follow Tivity Health.

Tivity Health (NASDAQ:TVTYGet Rating) last posted its quarterly earnings data on Thursday, February 24th. The company reported $0.30 earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.38 by ($0.08). Tivity Health had a net margin of 21.80% and a return on equity of 99.51%. The company had revenue of $126.80 million for the quarter, compared to analysts’ expectations of $126.57 million. During the same quarter last year, the business posted $0.38 EPS. The business’s quarterly revenue was up 26.0% compared to the same quarter last year.

A number of analysts recently commented on the stock. Credit Suisse Group lifted their target price on shares of Tivity Health from $29.00 to $31.00 and gave the stock a “neutral” rating in a research note on Friday, March 11th. William Blair reiterated a “market perform” rating on shares of Tivity Health in a research note on Thursday, February 24th. Barrington Research downgraded Tivity Health from an “outperform” rating to a “market perform” rating in a report on Tuesday, April 5th. Truist Financial upped their price target on Tivity Health from $28.00 to $30.00 in a research note on Wednesday, January 5th. Finally, Zacks Investment Research lowered Tivity Health from a “hold” rating to a “sell” rating in a research note on Tuesday, March 1st. One research analyst has rated the stock with a sell rating, six have assigned a hold rating and one has issued a buy rating to the company’s stock. According to MarketBeat, Tivity Health presently has a consensus rating of “Hold” and an average price target of $30.67.

Shares of NASDAQ:TVTY opened at $32.16 on Friday. Tivity Health has a fifty-two week low of $21.25 and a fifty-two week high of $32.89. The firm has a market cap of $1.60 billion, a price-to-earnings ratio of 15.46, a P/E/G ratio of 1.80 and a beta of 2.30. The company has a debt-to-equity ratio of 3.23, a quick ratio of 2.24 and a current ratio of 2.24. The firm has a fifty day moving average price of $29.88 and a 200 day moving average price of $26.93.

Several hedge funds and other institutional investors have recently modified their holdings of the company. National Bank of Canada FI purchased a new position in shares of Tivity Health in the 4th quarter worth about $28,000. O Shaughnessy Asset Management LLC purchased a new position in shares of Tivity Health during the 3rd quarter valued at about $39,000. Mutual of America Capital Management LLC increased its stake in Tivity Health by 9.3% in the 3rd quarter. Mutual of America Capital Management LLC now owns 5,892 shares of the company’s stock worth $136,000 after acquiring an additional 503 shares during the last quarter. Royal Bank of Canada lifted its holdings in shares of Tivity Health by 59.1% in the 3rd quarter. Royal Bank of Canada now owns 6,386 shares of the company’s stock worth $147,000 after buying an additional 2,373 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank increased its position in Tivity Health by 118.5% during the 4th quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 6,411 shares of the company’s stock valued at $170,000 after buying an additional 3,477 shares in the last quarter. Hedge funds and other institutional investors own 91.07% of the company’s stock.

About Tivity Health (Get Rating)

Tivity Health, Inc provides fitness and health products and solutions in the United States. The company offers SilverSneakers to members of Medicare Advantage, Medicare Supplement, and group retiree plans; Prime Fitness, a fitness facility access program through commercial health plans, employers, and other sponsoring organizations; virtual fitness experiences, including live instructor-led classes; and WholeHealth living program, a continuum of services related to complementary, alternative, and physical medicine.

Further Reading

Get a free copy of the Zacks research report on Tivity Health (TVTY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Earnings History and Estimates for Tivity Health (NASDAQ:TVTY)

Receive News & Ratings for Tivity Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tivity Health and related companies with MarketBeat.com's FREE daily email newsletter.